Guanze Medical Information Industry (Holding) Co., Ltd. ( (HK:2427) ) has issued an announcement.
Guanze Medical Information Industry (Holding) Co., Ltd. announced its audited consolidated results for the year ended December 31, 2024. The company reported a slight decrease in revenue from RMB 156,072,000 in 2023 to RMB 155,740,000 in 2024. Despite this, the company faced increased costs in sales and research and development, leading to a decrease in gross profit from RMB 85,405,000 to RMB 62,786,000. The profit before tax also declined from RMB 38,650,000 in 2023 to RMB 26,309,000 in 2024, with the total comprehensive income for the year dropping from RMB 27,922,000 to RMB 17,450,000. These results indicate a challenging financial year for the company, impacting its profitability and potentially its market positioning.
More about Guanze Medical Information Industry (Holding) Co., Ltd.
Guanze Medical Information Industry (Holding) Co., Ltd. is a company incorporated in the Cayman Islands, focusing on the medical information industry. It is listed on the Hong Kong Stock Exchange under the stock code 2427.
YTD Price Performance: 2.94%
Average Trading Volume: 687,307
Technical Sentiment Signal: Buy
For detailed information about 2427 stock, go to TipRanks’ Stock Analysis page.